{"certainAgreement":{"otherDetails":"Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"There were some limitations of the study resulting in poor overlap between study arms suggesting that groups are not well comparable in terms of the observed confounding characteristics used for adjustment. This should be taken into consideration when interpreting results."},"pointOfContact":{"email":"ClinicalTrials.gov_Inquiries@pfizer.com","organization":"Pfizer Inc.","phone":"1-800-718-1021","title":"Pfizer ClinicalTrials.gov Call Center"}}